What can comparative databases contribute to the evaluation of new technology?
Detre, K.
Journal of Invasive Cardiology 5(2): 53-59
1993
ISSN/ISBN: 1042-3931 PMID: 10148626 Document Number: 406637
Document emailed within 1 workday
Related Documents
Olbricht, S.M. 2015: What does empathy contribute in this age of science and technology? Cutis 96(2): 78-79Hayden, W.J. 1997: Dental health services research utilizing comprehensive clinical databases and information technology Journal of Dental Education 61(1): 47-55
Cecchini, S.; Scott, C. 2003: Can information and communications technology applications contribute to poverty reduction? Lessons from rural India Information Technology for Development 10(2): 73-84
Li, C.; Zhang, P.; Wang, X.; Liu, X.; Zhao, Y.; Sun, C.; Wang, C.; Yang, R.; Zhou, L. 2015: Development and comparative evaluation of up-converting phosphor technology based lateral flow assay for rapid detection of Yersinia pestis, Bacillus anthracis spore and Brucella spp Zhonghua Yu Fang Yi Xue Za Zhi 49(1): 3-8
Mikhaĭlitsyn, F.S.; Petrov, I.F.; Bol'shakova, A.I.; Lebedeva, M.N.; Lychko, N.D. 1995: The technology for manufacturing antiparasitic preparations. 4. the development of a technology for producing the anthelmintic bromoksan in finely dispersed form and the evaluation of its antifascioliasis activity Meditsinskaia Parazitologiia i Parazitarnye Bolezni 3: 41-42
Tsumoto, S.; Tanaka, H. 1998: Automated acquisition of rules from clinical databases and its evaluation Studies in Health Technology and Informatics 52 Pt 1: 649-653
Mikhaĭlitsyn, F.S.; Drusviatskaia, S.K.; Uvarova, N.A.; Taits, S.Z.; Stoianovich, F.M.; Vol'kenshteĭn, I.B.; Lebedeva, M.N.; Krotov, A.I.; Lychko, N.D. 1994: The technology for manufacturing antiparasitic preparations. 3. the development of a technology for producing the anthelmintic embovin (pyrantel embonate) in finely dispersed form and the evaluation of its anthelmintic properties Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2: 24-26
Benson, J.; Andersen, K.; Healy, J.; Brahmi, D. 2017: What Factors Contribute to Postabortion Contraceptive Uptake By Young Women? A Program Evaluation in 10 Countries in Asia and sub-Saharan Africa Global Health Science and Practice 5(4): 644-657
Jørgensen, M.S.; Jørgensen, U. 2009: Green technology foresight of high technology: a social shaping of technology approach to the analysis of hopes and hypes Technology Analysis-Strategic Management 21(3): 363-379
Sakai, F.; Kondo, M.; Ito, H.; Ota, N. 1982: Evaluation of the extent of basic nursing technology knowledge at the end of the program at our school--self-evaluation by the students and a survey of frequencies of clinical training sessions Kango Tenbo. Japanese Journal of Nursing Science 7(3): 218-224
Haller, B.; Bruder, W. 1979: Comparative scanning electron-microscopy studies of leaf fragments in criminological technology. 1 Archiv für Kriminologie 163(3-4): 105-111
Barban, P.S. 1976: The complex technology of producing rickettsial diagnostic immunoglobulin preparations and comparative technico-economic indices Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 45-49
Ding, C.; Jones, G. 2003: Technology evaluation: MRA, Chugai Current Opinion in Molecular Therapeutics 5(1): 64-69
Zhang, Z. 2001: Technology evaluation: MG-98, MethylGene Current Opinion in Molecular Therapeutics 3(6): 599-604
Reinis, M. 2005: Technology evaluation: NV-1020, MediGene Current Opinion in Molecular Therapeutics 7(4): 366-375
Errasti, F. 1996: Various sources of medical technology evaluation Revista de Medicina de la Universidad de Navarra 40(4): 4-5
Paul, S.ép. 2003: Technology evaluation: CpG-7909, Coley Current Opinion in Molecular Therapeutics 5(5): 553-559
Galanis, E. 2002: Technology evaluation: Allovectin-7, Vical Current Opinion in Molecular Therapeutics 4(1): 80-87
Mukhtar, M.; Parveen, Z.; Pomerantz, R.J. 2000: Technology evaluation: PRO-542, Progenics Pharmaceuticals inc Current Opinion in Molecular Therapeutics 2(6): 697-702
Doehn, C.; Jocham, D. 2000: Technology evaluation: TG-1031, Transgene SA Current Opinion in Molecular Therapeutics 2(1): 106-111